EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Cyanopyrimidine Derivatives as Potential Anticancer Agents

Rania H Abd El-Hameed, Omnia Aly iD, Mariem E Mohamed, Amal F Gharib iD, Mosaad S Mohamed, Ashraf Ali iD, Zainab M Khoder iD, Heba Taha iD, Samar S Fatahala iD

Molecules · 2025

DOI: 10.3390/molecules30071453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Rania H Abd El-Hameed und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Cairo 11795, Egypt. Hauptthemen laut MEDLINE: Antineoplastic Agents, Pyrimidines. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taif University, Taif University, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Bcl-2 family’s anti-apoptotic proteins, particularly Mcl-1, offer a viable avenue for cancer treatment since cancer cells can undergo apoptosis when their selective suppression occurs. Mcl-1 is essential for controlling the advancement of the cell cycle, as well as apoptosis. There is a constant clinical need for more potent treatments for breast and ovarian malignancies, even with advancements in the discovery of anticancer drugs. By synthesizing cyanopyrimidine derivatives that demonstrate both dual inhibitory activity against Mcl-1 and Bcl-2, and successful cell cycle arrest, our research seeks to contribute to the development of innovative therapeutic medicines. We created a number of new 6-substituted cyanopyrimidines and tested their anticancer effects on SKOV-3 and MCF-7 cell lines as well as apoptosis and cell cycle arrest assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsPyrimidinesHumansApoptosisCell Line, TumorMCF-7 CellsCell Cycle CheckpointsMyeloid Cell Leukemia Sequence 1 ProteinCell ProliferationProto-Oncogene Proteins c-bcl-2Structure-Activity RelationshipFemaleMolecular Structure

Stichwörter der Autor:innen

Bcl-2Mcl-1SKOV3breast cancercell cycledockingovarian cancer

Substanzen

Antineoplastic AgentsPyrimidinesMyeloid Cell Leukemia Sequence 1 ProteinProto-Oncogene Proteins c-bcl-2

Autor:innen und Institutionen

  • Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Cairo 11795, Egypt.
  • Medical Biochemistry Department, National Research Centre, Dokki 12622, Egypt.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif 21944, Saudi Arabia.
  • Department of Reproductive Health Research and Family Planning, National Research Centre, Dokki 12622, Egypt.
  • Department of Chemistry, The State University of New York, Buffalo, NY 14260, USA.
  • Biochemistry and Molecular Biology Department, Faculty of Pharmacy, Helwan University, Cairo 11795, Egypt.

ORCID-Profile: Omnia Aly, Amal F Gharib, Ashraf Ali, Zainab M Khoder, Heba Taha, Samar S Fatahala

Förderung

  • Taif University
  • Taif University, Saudi Arabia

Zitieren

APA

Abd El-Hameed, R. H., Aly, O., Mohamed, M. E., Gharib, A. F., Mohamed, M. S., Ali, A., Khoder, Z. M., Taha, H., & Fatahala, S. S. (2025). Novel Cyanopyrimidine Derivatives as Potential Anticancer Agents. Molecules. https://doi.org/10.3390/molecules30071453

Vancouver

Abd El-Hameed RH, Aly O, Mohamed ME, Gharib AF, Mohamed MS, Ali A, et al. Novel Cyanopyrimidine Derivatives as Potential Anticancer Agents. Molecules. 2025. doi:10.3390/molecules30071453

BibTeX
@article{AbdElHameed2025,
  author = {Abd El-Hameed, Rania H and Aly, Omnia and Mohamed, Mariem E and Gharib, Amal F and Mohamed, Mosaad S and Ali, Ashraf and Khoder, Zainab M and Taha, Heba and Fatahala, Samar S},
  title = {Novel Cyanopyrimidine Derivatives as Potential Anticancer Agents},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30071453}
}
Kostenlos starten →